Ginkgo Bioworks Holdings Inc (NYSE: DNA) is -20.06% lower on its value in year-to-date trading and has touched a low of $5.00 and a high of $45.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DNA stock was last observed hovering at around $8.09 in the last trading session, with the day’s loss setting it -0.24%.
Currently trading at $7.85, the stock is 14.63% and -8.77% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.14 million and changing -2.97% at the moment leaves the stock -16.40% off its SMA200. DNA registered -78.52% loss for a year compared to 6-month loss of 0.77%. The firm has a 50-day simple moving average (SMA 50) of $8.6048 and a 200-day simple moving average (SMA200) of $9.39035.
The stock witnessed a 4.95% gain in the last 1 month and extending the period to 3 months gives it a -23.04%, and is 7.53% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.88% over the week and 11.17% over the month.
Ginkgo Bioworks Holdings Inc (DNA) has around 834 employees, a market worth around $455.56M and $227.04M in sales. Profit margin for the company is -240.94%. Distance from 52-week low is 57.00% and -82.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-47.37%).
with sales reaching $38.7M over the same period.The EPS is expected to grow by 50.10% this year, but quarterly earnings will post -23.79% year-over-year. Quarterly sales are estimated to grow 1.98% in year-over-year returns.
Ginkgo Bioworks Holdings Inc (DNA) Top Institutional Holders
219.0 institutions hold shares in Ginkgo Bioworks Holdings Inc (DNA), with institutional investors hold 87.31% of the company’s shares. The shares outstanding are 42.70M, and float is at 36.98M with Short Float at 30.81%. Institutions hold 81.55% of the Float.
The top institutional shareholder in the company is VIKING GLOBAL INVESTORS LP with over 143.09 million shares valued at $47.83 million. The investor’s holdings represent 6.9686% of the DNA Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 138.96 million shares valued at $46.46 million to account for 6.9327 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 134.43 million shares representing 6.5469% and valued at over $44.94 million, while ANCHORAGE CAPITAL GROUP, L.L.C. holds 3.4021 of the shares totaling 69.85 million with a market value of $23.35 million.
Ginkgo Bioworks Holdings Inc (DNA) Insider Activity
#####
Still, SEC filings show that on Apr 15 ’25, Che Austin (Officer) Proposed Sale 99 shares at an average price of $8.41 for $833.0. The insider now directly holds shares of Ginkgo Bioworks Holdings Inc (DNA).
